Cognitive recovery and restoration of cell proliferation in the dentate gyrus in the 5XFAD transgenic mice model of Alzheimer’s disease following 2-hydroxy-DHA treatment

[1]  A. Dangour,et al.  Omega 3 fatty acid for the prevention of cognitive decline and dementia , 2012, The Cochrane database of systematic reviews.

[2]  J. García-Verdugo,et al.  2-Hydroxyoleate, a nontoxic membrane binding anticancer drug, induces glioma cell differentiation and autophagy , 2012, Proceedings of the National Academy of Sciences.

[3]  P. Mukherjee,et al.  Ataxin-1 Poly(Q)-induced Proteotoxic Stress and Apoptosis Are Attenuated in Neural Cells by Docosahexaenoic Acid-derived Neuroprotectin D1 , 2012, The Journal of Biological Chemistry.

[4]  F. Gage,et al.  Adult hippocampal neurogenesis and its role in Alzheimer's disease , 2011, Molecular Neurodegeneration.

[5]  R. Agrawal,et al.  Omega-3 Fatty Acid Deficiency during Brain Maturation Reduces Neuronal and Behavioral Plasticity in Adulthood , 2011, PloS one.

[6]  P. Escribá,et al.  Sphingomyelin and sphingomyelin synthase (SMS) in the malignant transformation of glioma cells and in 2-hydroxyoleic acid therapy , 2011, Proceedings of the National Academy of Sciences.

[7]  A. Verkhratsky,et al.  Voluntary running and environmental enrichment restores impaired hippocampal neurogenesis in a triple transgenic mouse model of Alzheimer's disease. , 2011, Current Alzheimer research.

[8]  O. Shido,et al.  Protective effects of prescription n-3 fatty acids against impairment of spatial cognitive learning ability in amyloid β-infused rats. , 2011, Food & function.

[9]  A. Verkhratsky,et al.  Neurogenesis in Alzheimer’s disease , 2011, Journal of anatomy.

[10]  W. Gattaz,et al.  Insights into Alzheimer disease pathogenesis from studies in transgenic animal models , 2011, Clinics.

[11]  J. Gordon.  Oscillations and hippocampal–prefrontal synchrony , 2011, Current Opinion in Neurobiology.

[12]  M. Péter,et al.  Docosahexaenoic Acid Reduces Amyloid β Production via Multiple Pleiotropic Mechanisms* , 2011, The Journal of Biological Chemistry.

[13]  F. Calon,et al.  Docosahexaenoic Acid-Derived Neuroprotectin D1 Induces Neuronal Survival via Secretase- and PPARγ-Mediated Mechanisms in Alzheimer's Disease Models , 2011, PloS one.

[14]  Michael Weiner,et al.  Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. , 2010, JAMA.

[15]  G. Michael,et al.  Omega‐3 fatty acids reverse age‐related decreases in nuclear receptors and increase neurogenesis in old rats , 2010, Journal of neuroscience research.

[16]  Michael P. Demars,et al.  Impaired neurogenesis is an early event in the etiology of familial Alzheimer's disease in transgenic mice , 2010, Journal of neuroscience research.

[17]  Jose Julio Rodriguez,et al.  Serotonin fibre sprouting and increase in serotonin transporter immunoreactivity in the CA1 area of hippocampus in a triple transgenic mouse model of Alzheimer’s disease , 2010, The European journal of neuroscience.

[18]  H. Su.  Mechanisms of n-3 fatty acid-mediated development and maintenance of learning memory performance. , 2010, The Journal of nutritional biochemistry.

[19]  M. Ohno.  Failures to reconsolidate memory in a mouse model of Alzheimer’s disease , 2009, Neurobiology of Learning and Memory.

[20]  P. Escribá,et al.  Pivotal role of dihydrofolate reductase knockdown in the anticancer activity of 2-hydroxyoleic acid , 2009, Proceedings of the National Academy of Sciences.

[21]  A. Marini,et al.  Subchronic Alpha-Linolenic Acid Treatment Enhances Brain Plasticity and Exerts an Antidepressant Effect: A Versatile Potential Therapy for Stroke , 2009, Neuropsychopharmacology.

[22]  Libin Cui,et al.  Improved spatial learning performance of fat-1 mice is associated with enhanced neurogenesis and neuritogenesis by docosahexaenoic acid , 2009, Proceedings of the National Academy of Sciences.

[23]  K. Shudo,et al.  Retinoic acid receptor stimulation protects midbrain dopaminergic neurons from inflammatory degeneration via BDNF‐mediated signaling , 2009, Journal of neurochemistry.

[24]  A. Verkhratsky,et al.  Impaired cell proliferation in the subventricular zone in an Alzheimer's disease model , 2009, Neuroreport.

[25]  Ghiam Yamin.  NMDA receptor–dependent signaling pathways that underlie amyloid β‐protein disruption of LTP in the hippocampus , 2009, Journal of neuroscience research.

[26]  M. Ohno,et al.  Impairments in remote memory stabilization precede hippocampal synaptic and cognitive failures in 5XFAD Alzheimer mouse model , 2009, Neurobiology of Disease.

[27]  P. Escribá,et al.  Minerval induces apoptosis in Jurkat and other cancer cells , 2008, Journal of cellular and molecular medicine.

[28]  N. Bazan,et al.  Docosahexaenoic acid and the aging brain. , 2008, The Journal of nutrition.

[29]  A. Verkhratsky,et al.  Impaired Adult Neurogenesis in the Dentate Gyrus of a Triple Transgenic Mouse Model of Alzheimer's Disease , 2008, PloS one.

[30]  K. Christian,et al.  BDNF: A key regulator for protein synthesis-dependent LTP and long-term memory? , 2008, Neurobiology of Learning and Memory.

[31]  T. Hartmann,et al.  Alzheimer’s disease: the lipid connection , 2007, Journal of neurochemistry.

[32]  Frank M LaFerla,et al.  Dietary Docosahexaenoic Acid and Docosapentaenoic Acid Ameliorate Amyloid-β and Tau Pathology via a Mechanism Involving Presenilin 1 Levels , 2007, The Journal of Neuroscience.

[33]  M. Ohno,et al.  BACE1 gene deletion prevents neuron loss and memory deficits in 5XFAD APP/PS1 transgenic mice , 2007, Neurobiology of Disease.

[34]  R. Vertes,et al.  Nucleus reuniens of the midline thalamus: Link between the medial prefrontal cortex and the hippocampus , 2007, Brain Research Bulletin.

[35]  E. McNeil,et al.  Long-lasting impairment in hippocampal neurogenesis associated with amyloid deposition in a knock-in mouse model of familial Alzheimer's disease , 2007, Experimental Neurology.

[36]  S. J. Martin,et al.  The rodent hippocampus and spatial memory: from synapses to systems , 2007, Cellular and Molecular Life Sciences.

[37]  O. Shido,et al.  Docosahexaenoic acid promotes neurogenesis in vitro and in vivo , 2006, Neuroscience.

[38]  M. Ohno,et al.  Intraneuronal β-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer's Disease Mutations: Potential Factors in Amyloid Plaque Formation , 2006, The Journal of Neuroscience.

[39]  Lars-Olof Wahlund,et al.  Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial. , 2006, Archives of neurology.

[40]  Karen Schindler,et al.  Phosphorylation of histone H4 Ser1 regulates sporulation in yeast and is conserved in fly and mouse spermatogenesis. , 2006, Genes & development.

[41]  Elizabeth J Johnson,et al.  Potential role of dietary n-3 fatty acids in the prevention of dementia and macular degeneration. , 2006, The American journal of clinical nutrition.

[42]  R. Uauy,et al.  Nutrition in Brain Development and Aging: Role of Essential Fatty Acids , 2006 .

[43]  D. German,et al.  Decreased adult hippocampal neurogenesis in the PDAPP mouse model of Alzheimer's disease , 2006, The Journal of comparative neurology.

[44]  M. Ohno,et al.  Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1 , 2006, The European journal of neuroscience.

[45]  M. Hasselmo,et al.  Hippocampal mechanisms for the context-dependent retrieval of episodes , 2005, Neural Networks.

[46]  Charles N Serhan,et al.  A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease. , 2005, The Journal of clinical investigation.

[47]  J. Wuu,et al.  Precursor form of brain‐derived neurotrophic factor and mature brain‐derived neurotrophic factor are decreased in the pre‐clinical stages of Alzheimer's disease , 2005, Journal of neurochemistry.

[48]  D. Abrous,et al.  Adult neurogenesis: from precursors to network and physiology. , 2005, Physiological reviews.

[49]  Takashi Morihara,et al.  A Diet Enriched with the Omega-3 Fatty Acid Docosahexaenoic Acid Reduces Amyloid Burden in an Aged Alzheimer Mouse Model , 2005, The Journal of Neuroscience.

[50]  J. Csernansky,et al.  Modulation of hippocampal cell proliferation, memory, and amyloid plaque deposition in APPsw (Tg2576) mutant mice by isolation stress , 2004, Neuroscience.

[51]  Petti T. Pang,et al.  Regulation of late-phase LTP and long-term memory in normal and aging hippocampus: role of secreted proteins tPA and BDNF , 2004, Ageing Research Reviews.

[52]  Lin Xie,et al.  Enhanced neurogenesis in Alzheimer's disease transgenic (PDGF-APPSw,Ind) mice. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[53]  Takashi Morihara,et al.  Docosahexaenoic Acid Protects from Dendritic Pathology in an Alzheimer's Disease Mouse Model , 2004, Neuron.

[54]  Paul M. Thompson,et al.  Mapping hippocampal and ventricular change in Alzheimer disease , 2004, NeuroImage.

[55]  Lin Xie,et al.  Increased hippocampal neurogenesis in Alzheimer's disease , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[56]  M. Mattson,et al.  Triple-Transgenic Model of Alzheimer's Disease with Plaques and Tangles Intracellular Aβ and Synaptic Dysfunction , 2003, Neuron.

[57]  D. Bennett,et al.  Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. , 2003, Archives of neurology.

[58]  M. Mattson,et al.  Disruption of neurogenesis by amyloid β‐peptide, and perturbed neural progenitor cell homeostasis, in models of Alzheimer's disease , 2002, Journal of neurochemistry.

[59]  P. Hof,et al.  Overexpression of Wild Type But Not an FAD Mutant Presenilin-1 Promotes Neurogenesis in the Hippocampus of Adult Mice , 2002, Neurobiology of Disease.

[60]  K. Ashe.  Learning and memory in transgenic mice modeling Alzheimer's disease. , 2001, Learning & memory.

[61]  Hee-Yong Kim,et al.  Mechanisms of action of docosahexaenoic acid in the nervous system , 2001, Lipids.

[62]  George Paxinos,et al.  The Mouse Brain in Stereotaxic Coordinates , 2001 .

[63]  S. Hossain,et al.  Chronic Administration Of Docosahexaenoic Acid Improves The Performance Of Radial Arm Maze Task In Aged Rats , 2001, Clinical and experimental pharmacology & physiology.

[64]  L. Eng,et al.  Glial Fibrillary Acidic Protein: GFAP-Thirty-One Years (1969–2000) , 2000, Neurochemical Research.

[65]  K. Sugioka,et al.  Chronic administration of docosahexaenoic acid improves reference memory-related learning ability in young rats , 1999, Neuroscience.

[66]  A. Hofman,et al.  Dietary fat intake and the risk of incident dementia in the Rotterdam study , 1997, Annals of neurology.

[67]  R. Beninger,et al.  Differential effects of scopolamine on working and reference memory of rats in the radial maze , 1984, Pharmacology Biochemistry and Behavior.

[68]  M. Ohno,et al.  7,8-Dihydroxyflavone, a Small-Molecule TrkB Agonist, Reverses Memory Deficits and BACE1 Elevation in a Mouse Model of Alzheimer's Disease , 2012, Neuropsychopharmacology.

[69]  W. Banks,et al.  Lipids and cognition. , 2010, Journal of Alzheimer's disease : JAD.

[70]  M. Shelanski,et al.  Increased neurogenesis in young transgenic mice overexpressing human APP(Sw, Ind). , 2007, Journal of Alzheimer's disease : JAD.

[71]  R. Uauy,et al.  Nutrition in brain development and aging: role of essential fatty acids. , 2006, Nutrition reviews.

[72]  P. Escribá,et al.  Membrane-lipid therapy: a new approach in molecular medicine. , 2006, Trends in molecular medicine.

[73]  L. Xie,et al.  Alzheimer病トランスジェニック(PDGF‐APPSw,Ind)マウス , 2004 .